Approval · Notice of Compliance 32152 · 2023
DICLOFENAC: Notice of Compliance 32152
Issued November 21, 2023
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 32152
- Date
- November 21, 2023
- Company
- Pharma Stulln Inc.Pointe-Claire, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to an Abbreviated New Drug Submission (SANDS), supplement
- Submission class
- Other
- Reason
- Update to the Product Monograph as per Advisement Letter
- Canadian reference product
- VOLTAREN OPHTHA (Alcon Canada Inc.)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| DICLOFENAC | Not yet assigned | — |
Medicinal ingredients
- DICLOFENAC SODIUM 0.1 PER